Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 36,608 |
|
|||||
| News | - | ||||||
| Day High | 1.44 | Low High |
|||||
| Day Low | 1.30 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Context Therapeutics Inc | CNTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.11 | -7.80% | 1.30 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.39 | 1.30 | 1.44 | 1.30 | 1.41 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 189 | 36,608 | $ 1.34 | $ 49,137 | - | 0.47 - 1.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 145 | $ 1.30 | USD |
Context Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 21.87M | 15.97M | - | 0 | -23.96M | -1.50 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Context Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CNTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.45 | 1.5242 | 1.30 | 1.39 | 24,720 | -0.15 | -10.34% |
| 1 Month | 1.25 | 1.60 | 1.23 | 1.40 | 79,076 | 0.05 | 4.00% |
| 3 Months | 1.03 | 1.60 | 0.9551 | 1.26 | 58,354 | 0.27 | 26.21% |
| 6 Months | 1.10 | 1.60 | 0.77 | 1.18 | 50,512 | 0.20 | 18.18% |
| 1 Year | 0.60 | 1.69 | 0.47 | 1.09 | 74,298 | 0.70 | 116.67% |
| 3 Years | 4.44 | 10.87 | 0.47 | 3.94 | 825,326 | -3.14 | -70.72% |
| 5 Years | 4.44 | 10.87 | 0.47 | 3.94 | 825,326 | -3.14 | -70.72% |
Context Therapeutics Description
| Context Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to improving the lives of women living with cancer. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. |
